A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine
Status:
Completed
Trial end date:
2017-07-25
Target enrollment:
Participant gender:
Summary
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, metyrapone
(Metopirone®), and the benzodiazepine receptor agonist, oxazepam (original trade name Serax®;
now marketed as oxazepam (generic) only).
This Phase 1b cocaine interaction study is being conducted in order to assess the safety and
PK of EMB-001 and cocaine in combination.